STOCK TITAN

NVMI (Nasdaq) Form 144: Director resale via Oppenheimer, $634K value

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

NVMI submitted a Form 144 reporting proposed sales of Ordinary shares through Oppenheimer & Co. Inc.. The filing lists 1,246 shares with an aggregate value of $634,400.90, and a reported outstanding share figure of 31,780,111 as of 05/18/2026. The filing also itemizes previously issued Restricted Stock Units granted on 06/23/2022 (1,814 RSUs), 05/18/2023 (1,704 RSUs) and 06/20/2024 (730 RSUs).

Positive

  • None.

Negative

  • None.

Insights

Form 144 reports planned resale of securities and related broker information.

The filing lists a proposed sale routed via Oppenheimer & Co. Inc. showing 1,246 Ordinary shares for an aggregate of $634,400.90, with 31,780,111 shown on the same line dated 05/18/2026. This reflects a single resale filing under Rule 144 disclosure mechanics.

Timing and exact execution mechanics are not detailed beyond the broker entry; subsequent trade completion or settlement details will appear in later filings or broker confirmations if executed.

Shares listed for resale 1,246 shares line item dated 05/18/2026
Aggregate value $634,400.90 aggregate value shown on sale line dated 05/18/2026
Reported outstanding figure 31,780,111 figure appearing on same sale line dated 05/18/2026
RSU grants (06/23/2022) 1,814 RSUs grant date 06/23/2022 listed under Securities To Be Sold
RSU grants (05/18/2023) 1,704 RSUs grant date 05/18/2023 listed under Securities To Be Sold
RSU grants (06/20/2024) 730 RSUs grant date 06/20/2024 listed under Securities To Be Sold
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Units financial
"Restricted Stock Units | Issuer | 1,814 | 06/23/2022"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Ordinary financial
"Ordinary | Oppenheimer & Co. Inc 85 Broad St. New York NY 10004"
Aggregate value financial
"1246 | 634400.90 | 31780111 | 05/18/2026"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does NVMI's Form 144 report?

It reports a proposed resale of Ordinary shares through Oppenheimer & Co. The form lists 1,246 shares with aggregate value $634,400.90 and a line dated 05/18/2026.

How many Restricted Stock Units are referenced in the filing for NVMI?

The filing itemizes three RSU grant lines. They are 1,814 RSUs (06/23/2022), 1,704 RSUs (05/18/2023) and 730 RSUs (06/20/2024) as listed in the excerpt.

Who is the broker handling the proposed sale in NVMI's Form 144?

Oppenheimer & Co. Inc. is named as the broker. The filing shows the broker address at 85 Broad St., New York, NY alongside the sale line dated 05/18/2026.

Does the Form 144 state when the shares will be sold?

The excerpt lists a filing date but not an execution date. The line includes 05/18/2026, but the document does not specify the actual trade execution or settlement timing.